PATEL SANJIV (President and CEO) sold 6.1% of their position (43.17K shares) of RELAY THERAPEUTICS, INC. on the open market
Open‑market sale worth $337.6K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/7/2026ACC: 0001193125-26-006328
DirectorOfficer· President and CEO
Since Jul 2020
-42.17K
Net shares
Net seller
$337.6K
Total sold
1
Open market trades
0B · 1S
2
Total transactions
994.00 acquired · 43.17K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+994.00
Price / share
$2.99
Trade value
$2.97K
% of position
0.1%
12/31/2025
703.22K→704.21K
Common Stock
Direct
Shares
−43.17K
Price / share
$7.82
Trade value
$337.57K
% of position
6.1%
1/6/2026
704.21K→661.04K
Total
Net shares
−42.17K
Net value
-$334.60K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/31/2025 | A · Award | +994.00 | $2.99 | $2.97K | 0.1% | 703.22K | 704.21K |
| Common Stock Direct | 1/6/2026 | S · Sale | −43.17K | $7.82 | $337.57K | 6.1% | 704.21K | 661.04K |
| Total | −42.17K | -$334.60K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned687.36K
Common Stock
IndirectShares owned199.55K
Total
886.90K indirect886.90K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 687.36K | Indirect |
| Common Stock | 199.55K | Indirect |
| Total | 886.90K | 886.90K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported